Dr. Mark Wu, MD

Dr. Wu practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Wu's NPI, 1619474616, was assigned on April 7, 2018. Dr. Wu graduated from Harvard Medical School in 2018. Dr. Wu holds California license A196874.

Dr. Wu's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Wu's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Wu to 2 more group practices and clinics, 2 home health agencies, 2 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wu practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Wu's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Dr. Wu's licenses on file in 3 states: California, Minnesota and Wisconsin.

CMS data shows 37 Medicare services from Dr. Wu across 2 procedure codes in 2024, for 76 Medicare patients. Medicare paid $2,519 for them. Every service was in an office.

CMS counts 76 Medicare patients who saw Dr. Wu in 2024. The largest group is 75 to 84, with 28 patients. 75% of them have arthritis, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wu's median patient age at 70, with 62% women.

In 2024, Dr. Wu wrote 371 Medicare Part D claims for 131 patients. 94% of them were for generic drugs. CMS names the drug for 327 of them, across 9 drugs with 11 or more claims each, at $3,149 in total drug cost. In 2023, CMS named 201 claims across 6 drugs.

Dr. Wu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wu as offering telehealth. CMS counts 33 procedures of hip replacement by Dr. Wu, more than 78% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Wu, published from 2018 to 2025. 2022 was the busiest year, with 10. The most frequent topics are Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee and Postoperative Complications. Dr. Wu has published most often in J Arthroplasty. Dr. Wu's most frequent co-authors are Niall Hayward Cochrane, MD, Thorsten Markus Seyler, MD, PhD and Elshaday S. Belay, MD.

CMS Open Payments shows 24 general payments to Dr. Wu from 6 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 51% of the total. Medical Device Business Services, Inc. paid the most, $1,792.

Dr. Wu graduated from Harvard Medical School in 2018.